Demographics (3)
- AGE - Age (phv00525633.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00525647.v1.p1)
- SEX - Biological sex (phv00525629.v1.p1)
Disease Events (9)
- CLINICAL_SUBTYPE - Clinical subtype (phv00525635.v1.p1)
- CLINICAL_SUBTYPE - Clinical subtype (phv00525646.v1.p1)
- ER - Estrogen receptor status (phv00525636.v1.p1)
- HER2 - Her2 protein expression status (phv00525638.v1.p1)
- PR - Progesterone receptor status (phv00525637.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00525648.v1.p1)
- STAGE - Tumor stage of sample (phv00525634.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00525650.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00525649.v1.p1)
Race and Ethnicity (1)
- RACE - Race of patient (phv00525641.v1.p1)
Substance Use (1)
- SMOKING - Smoking status of subject (phv00525639.v1.p1)
Other (10)
- AFFECTION_STATUS - Case control status of the subject for breast cancer; all subjects are breast cancer patients. (phv00525640.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00525644.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525643.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525628.v1.p1)
- IS_TUMOR - Tumor status (phv00525645.v1.p1)
- SAMPLE_ID - Sample ID (phv00525642.v1.p1)
- SAMPLE_ID - Sample ID (phv00525631.v1.p1)
- SUBJECT_ID - Subject ID (phv00525632.v1.p1)
- SUBJECT_ID - Subject ID (phv00525627.v1.p1)
- SUBJECT_ID - Subject ID (phv00525630.v1.p1)